These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 772425)

  • 21. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
    Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antihypertensive drugs on plasma renin activity and urinary excretion of prostaglandin E2.
    Blum M; Algueti A; Bauminger S; Aviram A; Ayalon D
    Prostaglandins Med; 1981 Oct; 7(4):261-6. PubMed ID: 7031725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.
    Weidmann P; Beretta-Piccoli C; Meier A; Keusch G; Glück Z; Ziegler WH
    Kidney Int; 1983 Feb; 23(2):320-6. PubMed ID: 6341684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
    Stokes GS; Weber MA; Thornell IR; Stoker LM
    Prog Biochem Pharmacol; 1974; 9():29-44. PubMed ID: 4612559
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
    Vaughan ED; Laragh JH; Gavras I; Bühler FR; Gavras H; Brunner HR; Baer L
    Am J Cardiol; 1973 Sep; 32(4):523-32. PubMed ID: 4729722
    [No Abstract]   [Full Text] [Related]  

  • 29. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
    Leonetti G; Terzoli L; Sala C; Bianchini C; Sernesi L; Zanchetti A
    Clin Sci Mol Med Suppl; 1978 Dec; 4():307s-309s. PubMed ID: 282074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin.
    Cowley AW; Skelton MM; Velasquez MT
    Hypertension; 1985; 7(3 Pt 2):I151-60. PubMed ID: 3888837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
    Lawton WJ; Fitz A; Grant C; Witte DL
    Circulation; 1979 May; 59(5):1063-9. PubMed ID: 428086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
    van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Renin-sodium profiling and antihypertensive response to beta blockade.
    Wallace JM; Laragh JH; Bühler FR
    N Engl J Med; 1975 Jun; 292(24):1295-6. PubMed ID: 1128594
    [No Abstract]   [Full Text] [Related]  

  • 35. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K
    Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F
    Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.